Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


Last --
Change Today 0.00 / 0.00%
Volume 0.0
157 On Other Exchanges
Symbol
Exchange
157 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

natural beauty bio-tech (157) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NATURAL BEAUTY BIO-TECH (157)

Related News

No related news articles were found.

natural beauty bio-tech (157) Related Businessweek News

No Related Businessweek News Found

natural beauty bio-tech (157) Details

Natural Beauty Bio-Technology Limited, an investment holding company, manufactures and sells skin care, beauty, and aromatherapeutic products, as well as health supplements and make-up products under the Natural Beauty brand name. The company also offers skin treatment, beauty and spa, and skin care consulting and beauty training services. Its spas provide various services, including hydrotherapy, facial treatment, body care, and skin care analysis. In addition, the company engages in the wholesale and retail of skin care and beauty products. As of December 31, 2014, it operated 1,364 spas and 14 concessionary counters. Natural Beauty Bio-Technology Limited operates in the People’s Republic of China, Taiwan, Hong Kong, Malaysia, and Macau. The company was founded in 1976 and is based in Wanchai, Hong Kong. Natural Beauty Bio-Technology Limited is a subsidiary of Standard Cosmos Limited.

609 Employees
Last Reported Date: 09/10/15
Founded in 1976

natural beauty bio-tech (157) Top Compensated Officers

Vice Chairman, Executive Director, Chairman o...
Total Annual Compensation: $358.0K
Executive Director, Member of Executive Commi...
Total Annual Compensation: $329.0K
Compensation as of Fiscal Year 2014.

natural beauty bio-tech (157) Key Developments

Natural Beauty Bio-Technology Ltd. Announces Board Changes, with Effect from February 1, 2016

Natural Beauty Bio-Technology Ltd. announced that, with effect from February 1, 2016, Mr. YANG Tze-Kaing will resign as an independent non-executive Director, the Chairman of the Nomination Committee and a member of the Audit Committee, Remuneration Committee and Executive Committee of the company; and Mr. HSIEH Pang-Chang will be appointed as an independent non-executive Director, the Chairman of the Nomination Committee and a member of the Audit Committee and Remuneration Committee of the company.

Natural Beauty Bio-Technology Limited Announces Management Changes

The board of directors of Natural Beauty Bio-Technology Limited announced that the term of employment of the current Chief Executive Officer of the group, Ms. CHANG Karen Yi Fen, will expire on January 1, 2016, and she has decided to cease to hold office as Chief Executive Officer of the group. The board announced that, with effect from December 21, 2015, Mr. HSIAO Wen-Chung, alias Mark Shaw has been appointed as the Chief Operating Officer of the group. The board further announced that, with effect from January 1, 2016, Mr. HSIAO will be appointed as Interim Chief Executive Officer of the group and will tentatively hold office as Chief Executive Officer, following the departure of Ms. CHANG. Mr. HSIAO joined the group on October 16, 2006 as the Chief Operating Officer, Taiwan and other markets. From November 2014 to November 2015, Mr. HSIAO was the Executive Vice President of Panion & BF Biotech Inc.

Natural Beauty Bio-Technology Ltd. Announces Board Changes

Natural Beauty Bio-Technology Ltd. announced that as a result of the disposal of CA NB's entire interest in Starsign, it was stated in the Composite Document that the Investor Directors (namely, Mr. Patrick Thomas Siewert, Mr. Gregory Michael Zeluck, Ms. Gong Zhizhi and Mr. Chang Hsiuguo) intended to resign as non-executive Directors with effect from the earliest time permitted under the Takeovers Code (which is the close of the Offers) pursuant to their respective resignation letters dated the date of the Acquisition Closing. On 18 December 2015, in order to devote more time to their respective business commitments, Mr. Francis Goutenmacher and Ms. Su-Mei Thompson also tendered their resignation letters such that they will both resign with effect from the earliest time permitted under the Takeovers Code (which is the close of the Offers). The Board announced that with effect from the close of the Offers on 18 December 2015: Mr. Patrick Thomas Siewert ceased to be a non-executive Director, the Vice Chairman of the Board, the Chairman of the Executive Committee of the Board, a member of the Nomination Committee of the Board and a member of the Remuneration Committee of the Board; Mr. Gregory Michael Zeluck ceased to be a non-executive Director, and a member of the Executive Committee; Ms. Gong Zhizhi ceased to be a non-executive Director, and a member of the Audit Committee of the Board; Mr. Chang Hsiuguo ceased to be a non-executive Director; Mr. Francis Goutenmacher ceased to be an independent non-executive Director, a member of the Audit Committee, a member of the Remuneration Committee, a member of the Executive Committee and a member of the Nomination Committee; and Ms. Su-Mei Thompson ceased to be an independent non-executive Director, the Chairperson of the Remuneration Committee, a member of the Audit Committee and a member of the Nomination Committee. The board also announced that, with effect from the close of the Offers on 18 December 2015, Mr. Lu Chi-Chant was appointed as an independent non-executive Director. Mr. Lu, aged 64, is currently an independent non-executive director of Eagle Nice (International) Holdings Limited, and an independent director of K Laser Technology Inc. and Li Peng Enterprise Co. Ltd. The board further announced that Mr. Lu has been appointed to fill the casual vacancy arising from the resignation of Ms. Su-Mei Thompson as Chairperson of the Remuneration Committee and a member of both the Audit Committee and Nomination Committee, all appointments with effect from the close of the Offers on 18 December 2015. The Board further announced that, with effect from 4:00 p.m. on 18 December 2015: Mr. Lee Ming-Ta (an executive Director) has been appointed as the Chairman of the Executive Committee and a member of the Nomination Committee; Dr. Su Chien-Cheng (an executive Director) has been appointed as a member of the Executive Committee; and Dr. Su Sh-Hsyu (a non-executive Director) has been appointed as a member of the Remuneration Committee.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
157:HK $0.98 HKD 0.00

157 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 157.
View Industry Companies
 

Industry Analysis

157

Industry Average

Valuation 157 Industry Range
Price/Earnings 16.2x
Price/Sales 3.7x
Price/Book 2.5x
Price/Cash Flow 16.2x
TEV/Sales 2.5x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NATURAL BEAUTY BIO-TECH, please visit www.nblife.com/ir. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.